Gene-Editing heart therapy tracked for 15 years
NCT ID NCT06112327
First seen Apr 10, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study follows about 116 people who received an experimental gene-editing therapy for heart disease or high cholesterol. Researchers will monitor participants for 15 years to check for side effects and measure changes in cholesterol levels. The goal is to understand the long-term safety and effects of this one-time treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Study Center
Auckland, New Zealand
-
Clinical Study Center
Christchurch, New Zealand
-
Clinical Study Center
London, United Kingdom
Conditions
Explore the condition pages connected to this study.